GlassScriptPhysician profile
Andrea E Martinez
NPI 1073973020
$1,463.06
in general payments reported to CMS, 2019-2025
17 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $390 · 2023: $154 · 2024: $581 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $565.72 | 2021-2024 | |
| Angiodynamics, INC. | $179.17 | 2022-2025 | Auryon Laser System 100-120 Vac |
| Inari Medical, INC. | $153.85 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lilly USA, LLC | $124.99 | 2024 | Mounjaro |
| Veryan Medical Incorporated | $120.00 | 2022 | |
| Endologix LLC | $68.20 | 2025 | Torus Stent Graft System, Endocross Device |
| Aveo Pharmaceuticals, INC. | $35.33 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.77 | 2024 | Xifaxan |
| Abbvie INC. | $29.35 | 2022 | |
| Abiomed | $28.56 | 2024 | Impella |
| Apollo Endosurgery US INC | $22.41 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $21.28 | 2024 | Rexulti |
| Acera Surgical, INC. | $17.93 | 2025 | Restrata Wound Matrix |
| Boston Scientific Corporation | $16.99 | 2021 | |
| Medtronic, INC. | $16.09 | 2024 | Intellis Adaptivestim |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.43 | 2024 | Cologuard Collection Kit |
| Averitas Pharma INC. | $14.99 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.